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INTRODUCTION
In the last three decades the prevalence of respi-
ratory symptoms has been increasing world-
wide thereby imposing an ever greater economic 
burden on the health care system and society. 
The most common chronic respiratory diseases 
are asthma and chronic obstructive pulmo-
nary disease (COPD). The natural history and 
response to therapy of asthma and COPD are 
different, but these two chronic disorders share 
one common functional feature, i.e. airflow 
limitation.
Recent studies have shown that the preva-
lence of asthma in several West European coun-
tries varies from 6 to 9% [1, 2, 3]. A lower inci-
dence of asthma has been reported in Eastern 
Europe, e.g., 2% in Estonia [4]. The worldwide 
prevalence of COPD is 0.8% according to the 
World Health Organization (WHO) published 
data [5]. Other reports note that the prevalence 
rate of COPD is substantially higher, at approx-
imately 4 to 6% in countries of both Northern 
and Southern Europe [6]. Reliable asthma and 
chronic bronchitis prevalence data are lacking 
for many parts of the world, including South 
Eastern Europe. To our knowledge, there are 
no published data regarding respiratory symp-
toms in adults in the Balkan countries. The 
current study was the first large epidemiologi-
cal investigation of the prevalence of obstruc-
tive airway diseases in South Eastern Europe, 
following European Community Respiratory 
Health Survey (ECRHS) protocol [7].
OBJECTIVE
The aim of this study was to estimate the prev-
alence of respiratory symptoms and smok-
ing habits, and to assess the prevalence of 
asthma and chronic bronchitis among adults 
in Belgrade, Serbia, as determined by mailed 
questionnaire.
METHODS
Study area
Serbia is a country located in the Balkans. The 
study covered Belgrade, the capital of Serbia. 
The area of Belgrade is 3224 km2 with a popu-
lation of 1,576,124 inhabitants, as recorded in 
2002.
Measurements of the daily mean concentra-
tions of sulphur dioxide (SO2), black smoke and 
nitrogen dioxide (NO2) often show substantial 
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air pollution in Belgrade, the inner city zone being the most 
affected. Atmospheric pollution data are reported as annual 
mean values, obtained from the official Belgrade environ-
mental control office. In 2001, the mean concentration for 
SO2 was 11 g/m3, for NO2 21 μg/m3, and for black smoke 
was 32 μg/m3 [7].
Study population
The study population was randomly selected from the city 
population register and stratified according to age (20-80 
years), male/female ratio 1:1, from three Belgrade areas: 
two central, and one on the outskirts. Each of these areas 
had a total population of approximately 150,000 people. 
Apart from the area of residence, the sample was divided 
into subgroups according to age, gender and smoking 
habits.
Individuals who returned the questionnaire were called 
“responders”. A subject was defined as a non-responder if 
he had not returned the third questionnaire after 120 days.
METHODS
The study was a postal survey with similar design as other 
studies, following ECRHS protocol [8-11].
The questionnaire
The questionnaire used was an ECRHS modified version 
of the International Union Tuberculosis Lung Diseases 
(IUATLD) questionnaire, which had been previously used 
in multinational studies [4, 9, 11]. In addition, five ques-
tions regarding bronchitis related symptoms and smoking, 
based on the British Medical Research Council (BMRC) 
questionnaire were included [12]. This version of the 
ECRHS questionnaire has already been used in an exten-
sive multinational survey [10]. The English version of the 
questionnaire was translated into Serbian, with back trans-
lation into English. The questionnaire included 14 ques-
tions about respiratory symptoms; the questions required 
either “yes” or “no” answers. Nine questions were used 
for the diagnosis of asthma and five questions for bron-
chitis-related symptoms and smoking habits. Subjects 
who currently smoked or had stopped smoking within 12 
months prior to the study were classified as smokers. Those 
who had stopped smoking for more than 12 months before 
the survey were classified as ex-smokers.
A copy of the questionnaire is shown in Appendix 1, 
and is referred to in the text below by the numbers given 
in Appendix 1.
The questionnaire was mailed to chosen participants 
in February 2003, with an explanatory letter and reply 
paid envelope (Mailing I). A reminder and new question-
naires were sent after two months if no reply was received 
(Mailing II) and a second reminder was sent four months 
later (Mailing III). To increase response rate the follow-
ing strategies were implemented: a short custom-designed 
coloured questionnaire with a personalized letter signed 
by a Faculty senior, and postage paid return envelope. 
Recipients were informed of the survey’s University of 
Belgrade sponsorship. The significance of the survey was 
widely covered in daily newspapers and on TV.
Approval for the study was obtained from the Ministry 
of Science, Technology and Development. Return of the 
questionnaire was taken as informed consent to participate.
Classification
Diagnoses of asthma and chronic bronchitis were based 
on answers to questions or the combinations of questions 
concerning respiratory symptoms. Subjects reporting use 
of asthma medications or having asthma attacks (Q5 or 
Q6) during the previous year were classified as having an 
asthma-related disorder (AD). Positive answers to ques-
tions related to wheeze occurring in the absence of colds 
(Q1 and Q1a and Q1b) combined to form a complex of 
asthmatic symptoms (AS). Those reporting problems with 
long-term cough and/or morning cough (Q8 and/or 9) 
and with phlegm (Q10) were classified as having bron-
chitis symptoms (BS).
Statistical analysis
Descriptive statistical analysis and frequency tables were 
done using the Statistica, version 6.0. The following initial 
APPENDIX 1. Questionnaire
The following questions are common to all centres of the 
ECRHS:
Q1.  Have you had wheezing or whistling in your chest 
at any time in the last 12 months?
Q1a.  Have you been at all breathless if wheezing noise is 
present?
Q1b.  Have you had wheezing or whistling even if with-
out cold?
Q2.  Have you woken up with a feeling of tightness in 
your chest at any time in the last 12 months?
Q3.  Have you been woken by attack of shortness of 
breath at any time in the last 12 months?
Q4.  Have you been woken by attack of coughing at any 
time in the last 12 months?
Q5.  Have you had asthma attack over the last 12 months?
Q6.  Are you currently taking any medicine (including 
inhalers, aerosols or tablets) for asthma?
Q7.  Do you have any nasal allergies including “hay 
fever”?
Q8.  Have you had problems with pro-longed cough over 
recent years?
Q9.  Do you usually cough in the morning?
Q10.  Do you usually cough up phlegm?
Q11.  Do you smoke (answer yes even if you smoke only a 
few cigarettes or pipes per week, or if you quit smok-
ing less than one year ago)?
Q12.  Are you an ex-smoker (quitted smoking for over one 
year ago)?151
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symptom prevalence by subsequent contacts showed that 
symptoms prevalence was higher in early compared to late 
responders (64.8% vs. 22.6%; p<0.0001). Significantly more 
smokers were identified in the early compared to the late 
responders (36.4% vs. 25.4%; p<0.0001).
Smoking habits
Smoking habits are shown in Table 2. Current smokers 
constituted 37.2% of the total, 17.0% were ex-smokers, and 
45.8% had never smoked. Of interest is that significantly 
more women than men were smokers (51.8% vs. 47.9%; 
p<0.001) in all age groups. There were 353 current smok-
ers younger than 30 years i.e., 22.1% of all young partici-
pants. According to age group, the highest proportion of 
current smokers was found in subjects aged 50-55 years of 
both sexes (10.2% men, and 11.9% women).
Respiratory symptoms
No respiratory symptoms were reported by 1,021 subjects 
(20.1%). Among them, 22.2% were smokers, 41.2% ex-smok-
ers, and 36.5% non-smokers.
The prevalence of respiratory symptoms according to 
age and smoking habits is shown in Table 3. Four-fifths 
of participants reported respiratory symptoms. The most 
common symptoms were longstanding cough, 32.2%, and 
sputum production, 30.4%. The prevalence of wheezing 
was 30.3%, nasal allergies 19.4%, and asthma attacks 4.4%. 
Current use of asthma medication was reported by 5.6% 
subjects.
The prevalence of respiratory symptoms increased with 
age (p<0.05). Chronic cough increased with age ranging 
from 5.7% in age group 20-25 years to 12.6% in age group 
65-70 years. Also, productive cough increased with age 
ranging from 4.6% in the 20-25 years age group to 13.3% 
in the 65-70 years age group.
The prevalence rates for respiratory symptoms were 
almost equal between men and women. Attacks of breath-
lessness and/or cough, waking up with chest tightness, 
allergic rhinitis and long-term cough were more common 
in women than in men. The only symptom more frequently 
Table 3. Positive answers to respiratory questionnaire according to gender and smoking status
Question Number of positive 
answers (%)
Gender (N) Smoking habits (N)
Male Female p Current smoker Non-smoker p
Q1 1539 (30.3) 737 802 >0.05 844 479 <0.0001
Q1a 1027 (20.2) 477 550 >0.05 506 354 <0.0001
Q1b 966 (19.0) 467 499 >0.05 576 268 <0.0001
Q2 1158 (22.8) 517 641 0.003 533 449 <0.0001
Q3 784 (15.4) 347 437 <0.01 300 343 >0.05
Q4 1306 (25.7) 556 750 <0.0001 837 499 <0.0001
Q5 223 (4.4) 100 123 >0.05 71 103 >0.05
Q6 282 (5.6) 128 154 >0.05 101 117 >0.05
Q7 987 (19.4) 414 573 <0.0001 346 482 0.056
Q8 1629 (32.1) 712 917 <0.0001 746 650 <0.0001
Q9 1121 (22.1) 567 554 >0.05 665 331 <0.0001
Q10 1542 (30.2) 868 674 <0.0001 817 484 <0.0001
Table 1. Questionnaire response rate by sex and age for early and la-
te responders
Parameter Number %
Overall 5079 58.3
Males 2466 48.6
Females 2613 51.5
<45 years 2225 43.8
≥45 years 2872 56.2
≤4 weeks 3723 73.3
5-8 weeks 847 16.7
≥8 weeks 509 10.0
Table 2. Smoking habits by gender
Smoking 
habits
Male Female
N%N%
Smoker 907 36.8 982 37.6
Ex-smoker 594 24.1 270 10.3
Non-smoker 965 39.1 1361 52.1
Total 2466 100.0 2613 100.0
analyses were undertaken: response rate and distribution of 
symptoms in relation to age, gender, and smoking history.
RESULTS
Participants
Of 10,208 randomly selected subjects, 1,496 (14.7%) 
were excluded because they had changed addresses, were 
deceased or could not correctly be identified. Among those 
who were excluded 58% were aged below 45 years. These 
subjects were not included in the sample. The remain-
ing subjects constituted the adjusted study cohort; 3,633 
(41.7%) were non-responders according to our criteria.
In total, 5,079 completed questionnaires were received, 
a 58.3% response rate of the actual study sample. The ques-
tionnaire response rate is given in Table 1. The response 
rate was higher among women (51.4% vs. 48.6%; p=0.05). 
The response rate in the older age group was higher than in 
those younger than 45 years (56.2% vs. 43.8%; p<0.0001). 
The lowest participation rate (38.9%) was in the age group 
aged 35-40 years, and the highest rate (64.5%) was in those 
aged 65-70 years. There was no gender difference in early 
responders (51.3% vs. 48.7%; p=0.07). The analysis of 152
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reported in men was productive cough. Wheezing, breath-
lessness, wheezing not induced by cold, asthma attacks, 
current asthma medication use, and morning cough were 
equally reported by both women and men.
The prevalence of all symptoms except morning 
dyspnoea attacks, asthma attacks and current use of 
asthma medication, were significantly higher in smokers 
compared to nonsmokers. Nonsmokers reported allergic 
rhinitis more frequently than smokers. The prevalence of 
allergic rhinitis was not significantly different for younger 
subjects compared to those older than 45 years (8.2% vs. 
10.8%; p=0.2).
Asthma and chronic bronchitis
The overall prevalence of asthma-related disorder (AD) 
was 6.8%, of asthmatic symptoms (AS) 12.5%, and of symp-
toms of bronchitis (BS) 21.6%. Of the participants with AD, 
80% had AS. Of the participants with AD, 53.7% had BS. 
Of the subjects with BS, 19% had AS. The prevalence of 
AD was significantly more common in older subjects, i.e., 
aged over 45 years (4.5% vs. 2.0%; p<0.00001). There were 
241 (4.7%) participants with both AD and allergic rhinitis, 
and 79 (1.6%) with a combination of allergic rhinitis and 
AS and AD. Allergic rhinitis and BS were reported by 321 
(6.3%) subjects. The prevalence of AS, AD and BS accord-
ing to age and gender is shown in Table 4.
DISCUSSION
Completed questionnaire dealing with the subject suffer-
ing from respiratory diseases have high reliability and 
specificity in epidemiological studies. Self-administered 
and mailed questionnaires are the main instruments to 
assess the prevalence of asthma and chronic bronchitis 
in these studies. The data about the prevalence of chronic 
lung diseases show a wide variation across different stud-
ies and countries, which can be accounted for by several 
factors, such as different questionnaires, varying prevalence 
of risk factors and differences in response rate.
This study was the first large scale-study about respi-
ratory symptoms and diseases performed in the Balkans. 
The study is a part of comparative epidemiological studies 
in progress in Serbia and was aimed to estimate the preva-
lence not only of respiratory symptoms, but also of smoking 
habits, asthma and chronic bronchitis in Belgrade. Belgrade 
was selected as the study area because it is the capital of 
Serbia and 25% of the total population lives there. People 
with different ethnicities and nationalities migrated from 
other cities or rural areas to the capital, especially after the 
wars in the 1990’s. Therefore, Belgrade represents a snap-
shot of Serbia.
We performed this study using questionnaires similar to 
previous European ones which are based on validated ques-
tionnaires concerning respiratory symptoms and smoking 
habits [1, 4, 8-13]. Comparison of our findings to those 
of earlier surveys that utilized identical methodology is 
important but difficult because of differences in location 
and socio-demographic characteristics.
The number of unidentified persons was very high in 
our study, more than in other surveys [1, 4, 8-14]. Belgrade 
city population register is not regularly updated and infor-
mation on inhabitants who have moved abroad, changed 
address, or are deceased, is frequently unavailable. More 
than half of the excluded subjects were younger than 45 
years and had probably emigrated because of the war in 
the former Yugoslavia during the 1990’s.
The response rate may vary from country to country 
and population centres as a result of differing cultural 
and societal attitudes. The response rate in our study was 
58.3% which corresponds closely to the 56% response rate 
of the Australian study [14]. However, our study response 
rate is much lower compared to similar ones performed 
in Northern Europe, which reported compliance of 72% 
to 90.5% [1, 4, 8-11]. It was observed in studies from 1991 
to the present that response rate increased as the number 
of postal surveys increased [3, 8, 10-13]. Our study was 
the first postal health survey conducted in Serbia and we 
expected a lower response rate than that which actually 
occurred.
The response rate decreased with subsequent mailings, 
as in the Swedish study [10]. In our study women and 
older participants generally responded more frequently, 
as was the case in other health surveys [4, 8, 10]. Subjects 
with respiratory symptoms are more likely to participate 
than asymptomatic subjects [15]. Older subjects generally 
responded more promptly in our study, similar to other 
health surveys [10, 16]. Although other authors found that 
women responded sooner and more often than men, we 
did not find a significant difference in gender between 
early and late responders. In both our survey and a previ-
ous Italian one [16], late responders, and probably also 
non-responders, had a lower symptom prevalence than 
early responders.
Tobacco use is the most important risk factor for most 
respiratory symptoms and diseases. The prevalence of 
current smokers was high in our study (37.2%), but similar 
to Swedish and Finnish studies [8, 10]. In both a Swedish 
and Italian respiratory health survey [10, 16], late respond-
ers had a higher prevalence of smoking than early respond-
ers, as was the case in our study. Comparing the prevalence 
of smoking in the Balkans, the rate in Croatia Adriatic 
islands (22.7% in men and 22.1% in women) is lower than 
that in Belgrade [17]. In postal respiratory health surveys, 
the highest prevalence of smoking was noted in Estonia 
Table 4. The prevalence of asthma disorder (AD), asthma symptoms (AS) 
and bronchitis symptoms (BS) according to age and gender of patients
Age 
(years)
Asthma 
disorder
Asthma 
symptoms
Bronchitis 
symptoms
MFMFMF
20–35 24 22 56 62 94 73
36–64 69 88 153 182 319 293
≥65 47 77 85 95 188 141
Overall 345 (6.8%) 633 (12.5%) 1098 (21.6%)
AS: Q1, Q1a and Q1b; AD: Q5 or Q6; BS: Q8 and/or Q9, and Q10153
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where it varied from 39.1% to 42.5% [4]. In our survey 
current smoking was more common in early responders 
than late responders, which differs from other studies [10, 
16]. Early responders had a higher frequency of respira-
tory symptoms due to smoking.
In most previous studies smoking was more common 
in men [4, 8, 10]. However, in our study the prevalence of 
female smokers was considerably higher.
In many developed countries, the proportion of smok-
ers in the total population has decreased during the last 
several decades. However, smoking is a common habit 
among young adults in Serbia (22.1%). The percentage 
of young current smokers varied widely from country to 
country, ranging from 20.1% (Portland, USA) to 56.9% 
(Oviedo, Spain) [18]. Surprisingly, 48% of 20 year-old Swiss 
conscripts were current smokers [19]. In subjects aged 20 to 
29 years, smoking was most common in Northern Finland 
(47% in men and 40% in women), while it was less common 
in Northern Sweden (16.0% in men and 25.7% in women) 
[20]. In Greek students, cigarette smoking was higher 
among adolescent females than in adolescent males (40.9% 
vs. 34.3%) [21]. These findings provide clear justification 
for initiating smoking prevention programs in schools.
In this study we divided symptomatic participants into 
three groups: 1) those with an “asthma-related” disorder 
(AD); 2) those afflicted with asthmatic symptoms (AS); 
and 3) those exhibiting bronchitis symptoms (BS). This 
classification of symptoms was used in previous epidemi-
ological studies [10, 22].
There is a widespread variation in self-reported attacks 
of asthma and asthma-like symptoms. This variation 
includes variations among countries, among centres in 
different countries that use the same language, and among 
centers in the same country using the same language [1]. 
The prevalence rate of 6.8% for AD in our study is slightly 
higher than the 6.1% reported in a Swedish study [10]. 
Meren et al. [4] found that 6.6% of participants reported 
a combination of symptom including “attacks of short-
ness of breath” and “recurrent wheezing”. In the Croatian 
islands, Zuskin et al. [17] reported the prevalence of asthma 
as being 3.9-4.5%.
The importance of performing clinical examination in 
epidemiological studies of asthma prevalence has been 
emphasized since 1987 [23]. In an Estonian survey, the 
prevalence of physician-diagnosed asthma was much lower 
than a combination of symptoms [4]. In our study, the defi-
nition of AD does not rely on the physician’s diagnosis, 
but rather on related symptoms and asthma medication. 
Therefore, based on the results of this questionnaire we can 
not accurately estimate the prevalence of asthma in Serbia.
The prevalence of AS in our study (12.5%) was higher 
than in Sweden (7.4%) [10]. We anticipated the higher 
prevalence of such symptoms in Serbia, because of the 
influence of tobacco smoke and the greater percentage 
of smokers. The combination of AD and allergic rhini-
tis was reported as being 4.7% and it can be assumed that 
69.7% patients with AD also reported allergic rhinitis. It 
is well known that 40-70% of patients with asthma have 
allergic rhinitis [24]. Bronchitis symptoms were reported 
by 21.6% of subjects in our study, which is higher than in 
similar studies. Variations in prevalence rates for chronic 
bronchitis have been well documented in various countries. 
For example, these symptoms were reported in Finland in 
4.8% [9], in Sweden 12.9% [10], in England 16.7% [15], 
and in Nepal in 18.3% [25] of adults. Cerveri et al. noted 
the incidence of chronic bronchitis to be 3.7% and 2.8% 
in young adult males and females, respectively [18]. It was 
reported that the prevalence of chronic bronchitis is higher 
in Eastern than in Western Europe [9].
Various risk factors such as exposure to polluted air, 
cigarette smoke, and overcrowded small apartments influ-
ence the prevalence of respiratory symptoms. In all these 
studies chronic bronchitis was strongly correlated to smok-
ing. Exposure to tobacco smoke may contribute to the high 
prevalence of chronic bronchitis in nonsmokers [20].
The main shortcoming of the present study is a rather 
low response rate to the questionnaire which created 
systematic bias in the results. Nevertheless, this study 
confirms the high prevalence of smoking, respiratory 
symptoms, asthma and chronic bronchitis symptoms in 
Serbia. Our results confirm gender and age differences 
with respect to most symptoms.
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This study was a part of the respiratory health survey of the 
Ministry of Science and Technological Development of the 
Republic of Serbia “Prevalence and risk factors of asthma 
and chronic obstructive disease in adults”, supported by 
the School of Medicine, University of Belgrade.
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КРАТАК САДРЖАЈ
Увод  У   п о  с л е д  њ е   т р и   д е  ц е  н и  ј е   п о  в е  ћ а  в а   с е   п р е  в а  л е н  ц и  ј а  
ре спи ра тор них бо ле сти у чи та вом све ту, што по ста је све ве-
ћ е   о п  т е  р е  ћ е  њ е   з а   с и  с т е м   з д р а в  с т в е  н е   з а  ш т и  т е .   П р е  в а  л е н -
ци ја  аст ме  у  зе мља ма  за пад не  Евро пе  је  6-9%,  а  хро нич не 
оп струк тив не  бо ле сти  плу ћа  (ХОБП)  у  све ту  0,8%.
Циљ ра  да Циљ ис  тра  жи  ва  ња је био да се про  це  ни пре  ва-
л е н  ц и  ј а  р е  с п и  р а  т о р  н и х  с и м п  т о  м а  и  н а  в и  к е  п у  ш е  њ а  и  и с  п и -
та  пре ва лен ци ја  аст ме  и  хро нич ног  брон хи ти са  код  од ра-
слих  ста нов ни ка  Бе о гра да.
М е  т о  д е   р а  д а   З а   п р и  к у  п љ а  њ е   п о  д а  т а  к а   к о  р и  ш ћ е н   ј е   у п и т-
ник за сно ван на про то ко лу Епи де ми о ло шке сту ди је о здра-
вљу  ре спи ра тор ног  си сте ма  европ ске  за јед ни це  (Euro pean 
Com mu nit y  Re spi ra tor y  He alth  Sur  vey  –  ECRHS ), ко  ји је по  слат 
по штом  на  адре се  10.208  слу чај но  ода бра них  ис пи та ни ка.
Ре зул та ти На упит ник је од го во ри ло 58,3% ис пи та ни ка. За-
п а  ж е  н а  ј е  в е  ћ а  у ч е  с т а  л о с т  р е  с п и  р а  т о р  н и х  с и м п  т о  м а  к о д  и с-
п и  т а  н и  к а   к о  ј и   с у   б р  ж е   о д  г о  в о  р и  л и .   В е  ћ и  н а   и с  п и  т а  н и  к а   с у  
би ли ак тив ни (37,5%) или бив ши (17,5%) пу ша чи. Ме ђу њи ма 
је  79,9%  има ло  ре спи ра тор не  симп то ме.  Нај че шћи  симп то-
м и  с у  б и  л и :  д у  г о  т р а  ј а н  к а  ш а љ  (32 , 2 %),  и с  к а  ш љ а  в а  њ е  с п у  т у -
ма (30,4%) и зви  жда  ње у гру  ди  ма (30,3%). На  па  де аст  ме је 
н а  в е  л о   4 , 4 %   и с  п и  т а  н и  к а ,   а   5 , 6 %   ј е   к о  р и  с т и  л о   л е  к о  в е   з а   а с т-
м у.   П р е  в а  л е н  ц и  ј а   р е  с п и  р а  т о р  н и х   с и м п  т о  м а   с е   п о  в е  ћ а  в а  л а  
са  ста ро сним  до бом  ис пи та ни ка.  Же не  су  че шће  од  му шка-
р а  ц а   н а  в о  д и  л е   д а   к а  ш љу,   и м а  ј у   н а  п а  д е   д и с п  н е ј е   и   к а  ш љ а ,  
сте за ње  у  гру ди ма  но ћу,  алер гиј ску  ки ја ви цу  и  хро нич ни 
ка шаљ.  Про дук тив ни  ка шаљ  је  био  че шћи  код  му шка ра ца. 
Пре ва лен ци ја  ско ро  свих  симп то ма  је  би ла  ве ћа  код  пу ша-
ча  не го  не пу ша ча.
За кљу чак У  С р  б и  ј и  ј е  в и  с о  к а  п р е  в а  л е н  ц и  ј а  р е  с п и  р а  т о р  н и х  
симп то ма,  аст ме,  хро нич ног  брон хи ти са  и  на ви ке  пу ше ња.
Кључ не ре чи: аст ма; хро нич на оп струк тив на бо лест плу ћа 
( ХО Б П );   с и м п  т о  м и ;   е п и  д е  м и  о  л о  ш к о   и с  т р а  ж и  в а  њ е ;   у п и т  н и к
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